Oxis International, Inc.

Click Here To EMAIL INQUIRY
Contact: Anthony J. Cataldo - CEO & Chairman
Web: http://www.oxisresearch.com
E-Mail:
Address: 468 N. Camden Dr., 2nd Floor, Beverly Hills, California 90210, USA
Phone: +1-(310)-860-5184, 800-547-3686 | Map/Directions >>

Profile: Oxis International, Inc. is the nutraceutical provider for a potent antioxidant, ergothioneine. We also have an extensive patent portfolio, and a portfolio of therapeutic compounds. Our lipid soluble antioxidant (LSA) molecules are designed to mimic the activity of the body's natural cell membrane-protecting antioxidant, vitamin E. The molecules from this series are 20 to 40 fold more potent than vitamin E, and move into cell membranes much more quickly, making them more appropriate as drugs than the natural vitamin. The primary disease targets for this series of molecules include neurodegenerative diseases such as Alzheimer's and Parkinson's disease, as well as cardiovascular diseases.

The company has revenues of USD 5-10 Million and is ISO 9000 certified. OTC:OXISE (SEC Filings)

12 Products/Services (Click for related suppliers)

• Antioxidant Anti Aging System

• Carbamazepine Fluorescence Polarization Immunoassay Test (FDA Code: LGI / 862.3645)

A neuroleptic drugs radioceptor assay test system is a device intended to measure in serum or plasma the dopamine receptor blocking activity of neuroleptic drugs and their active metabolites. A neuroleptic drug has anti-psychotic action affecting principally psychomotor activity, is generally without hypnotic effects, and is a tranquilizer. Measurements obtained by this device are used to aid in determining whether a patient is taking the prescribed dosage level of such drugs.

• Diphenylhydantoin Fluorescence Polarization Immunoassay (FDA Code: LGR / 862.3350)

A diphenylhydantoin test system is a device intended to measure diphenylhydantoin, an antiepileptic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of diphenylhydantoin overdose and in monitoring levels of diphenylhydantoin to ensure appropriate therapy.

• Drug Specific Calibrator (FDA Code: DLJ / 862.3200)

A clinical toxicology calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. A clinical toxicology calibrator can be a mixture of drugs or a specific material for a particular drug (e.g., ethanol, lidocaine, etc.). (See also 862.2 in this part.)

• Enzyme Immunoassay

• Enzyme Immunoassay Test

• Fluorescent Immunoassay Gentamicin Test (FDA Code: LCQ / 862.3450)

A gentamicin test system is a device intended to measure gentamicin, an antibiotic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of gentamicin overdose and in monitoring levels of gentamicin to ensure appropriate therapy.

• Phenobarbital Fluorescence Polarization Immunoassay Test (FDA Code: LGQ / 862.3660)

A phenobarbitol test system is a device intended to measure phenobarbital, an antiepileptic and sedative-hypnotic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of phenobarbital use or overdose and in monitoring levels of phenobarbital to ensure appropriate therapy.

• Quinidine Enzyme Immunoassay Test (FDA Code: LBZ / 862.3320)

A digoxin test system is a device intended to measure digoxin, a cardiovascular drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to ensure appropriate therapy.

• Theophylline Fluorescence Polarization Immunoassay Test (FDA Code: LGS / 862.3880)

A theophylline test system is a device intended to measure theophylline (a drug used for stimulation of the muscles in the cardiovascular, respiratory, and central nervous systems) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of theophylline overdose or in monitoring levels of theophylline to ensure appropriate therapy.

• Tobramycin Fluorescence Polarization Immunoassay Test (FDA Code: LFW / 862.3900)

A tobramycin test system is a device intended to measure tobramycin, an aminoglycoside antibiotic drug, in plasma and serum. Measurements obtained by this device are used in the diagnosis and treatment of tobramycin overdose and in monitoring levels of tobramycin to ensure appropriate therapy.

• Valproic Acid Enzyme Immunoassay Test (FDA Code: LEG / 862.3645)